相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Endocannabinoid System in Hepatic Glucose Metabolism, Fatty Liver Disease, and Cirrhosis
Ivonne Bazwinsky-Wutschke et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Role of endocannabinoid system in dopamine signalling within the reward circuits affected by chronic pain
Jakub Mlost et al.
PHARMACOLOGICAL RESEARCH (2019)
Endocannabinoid system and the expression of endogenous ceramides in human hepatocellular carcinoma
Jiayong Yang et al.
ONCOLOGY LETTERS (2019)
The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet?
Estefania Moreno et al.
FRONTIERS IN PHARMACOLOGY (2019)
Modulation of the Endocannabinoid System as a Potential Anticancer Strategy
Robert Ramer et al.
FRONTIERS IN PHARMACOLOGY (2019)
Melatonin prevents lung injury by regulating apelin 13 to improve mitochondrial dysfunction
Lu Zhang et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2019)
Apelin promotes hepatic fibrosis through ERK signaling in LX-2 cells
Ying Wang et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2019)
Crystal Structure of the Human Cannabinoid Receptor CB2
Xiaoting Li et al.
CELL (2019)
Loss of Apelin Augments Angiotensin II-Induced Cardiac Dysfunction and Pathological Remodeling
Teruki Sato et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Function and regulation of apelin/APJ system in digestive physiology and pathology
Zhen Huang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Cardioprotective apelin effects and the cardiac-renal axis: review of existing science and potential therapeutic applications of synthetic and native regulated apelin
Carina Ureche et al.
JOURNAL OF HUMAN HYPERTENSION (2019)
Circulating Endocannabinoids: From Whence Do They Come and Where are They Going?
Cecilia J. Hillard
NEUROPSYCHOPHARMACOLOGY (2018)
The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain
Giulia Donvito et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Hepatic and cardiac beneficial effects of a long-acting Fc-apelin fusion protein in diet-induced obese mice
Weimin Wang et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2018)
Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System
Shenglong Zou et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Cannabinoid Receptor 2-Deficiency Ameliorates Disease Symptoms in a Mouse Model with Alzheimer's Disease-Like Pathology
Anne-Caroline Schmoele et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
The balancing act of the liver: tissue regeneration versus fibrosis
Lucia Cordero-Espinoza et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Surprising outcomes in cannabinoid CB1/CB2 receptor double knockout mice in two models of ischemia
Sara Jane Ward et al.
LIFE SCIENCES (2018)
Liver fibrosis: Direct antifibrotic agents and targeted therapies
Detlef Schuppan et al.
MATRIX BIOLOGY (2018)
Therapeutic Benefit and Gene Network Regulation by Combined Gene Transfer of Apelin, FGF2, and SERCA2a into Ischemic Heart
Edith Renaud-Gabardos et al.
MOLECULAR THERAPY (2018)
The Hippocampus is a Critical Site Mediating Antidepressant-like Activity of Apelin-13 in Rats
Zhi-Yong Xiao et al.
NEUROSCIENCE (2018)
Vascular effects of apelin: Mechanisms and therapeutic potential
Amreen Mughal et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Inhibitory Regulation of Skin Fibrosis in Systemic Sclerosis by Apelin/APJ Signaling
Yoko Yokoyama et al.
ARTHRITIS & RHEUMATOLOGY (2018)
The STAT3 inhibitor S3I-201 suppresses fibrogenesis and angiogenesis in liver fibrosis
Zhuo Wang et al.
LABORATORY INVESTIGATION (2018)
Graphene-Dendrimer Nanostars for Targeted Macrophage Overexpression of Metalloproteinase 9 and Hepatic Fibrosis Precision Therapy
Pedro Melgar-Lesmes et al.
NANO LETTERS (2018)
Fc-apelin fusion protein attenuates lipopolysaccharide-induced liver injury in mice
Huifen Zhou et al.
SCIENTIFIC REPORTS (2018)
Cannabinoids in depressive disorders
Ewa Poleszak et al.
LIFE SCIENCES (2018)
Apelin inhibited epithelial-mesenchymal transition of podocytes in diabetic mice through downregulating immunoproteasome subunits β5i
Jiming Yin et al.
CELL DEATH & DISEASE (2018)
Apelin Is a Negative Regulator of Angiotensin II-Mediated Adverse Myocardial Remodeling and Dysfunction
Zhen-Zhou Zhang et al.
HYPERTENSION (2017)
Hepatic expression of cannabinoid receptors CB1 and CB2 correlate with fibrogenesis in patients with chronic hepatitis B
Erhei Dai et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2017)
PDGF signaling pathway in hepatic fibrosis pathogenesis and therapeutics
Hua-Zhong Ying et al.
MOLECULAR MEDICINE REPORTS (2017)
Mechanotransduction-modulated fibrotic microniches reveal the contribution of angiogenesis in liver fibrosis
Longwei Liu et al.
NATURE MATERIALS (2017)
Mechanisms of hepatic stellate cell activation
Takuma Tsuchida et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Apelin attenuates TGF-β1-induced epithelial to mesenchymal transition via activation of PKC-ε in human renal tubular epithelial cells
Li-Yan Wang et al.
PEPTIDES (2017)
Hypoxia preconditioning promotes cardiac stem cell survival and cardiogenic differentiation in vitro involving activation of the HIF-1α/apelin/APJ axis
Jingying Hou et al.
STEM CELL RESEARCH & THERAPY (2017)
Hepatitis C is now curable, but what happens with cirrhosis and portal hypertension afterwards?
Ivica Grgurevic et al.
CLINICAL AND EXPERIMENTAL HEPATOLOGY (2017)
An Update on Non-CB1, Non-CB2 Cannabinoid Related G-Protein-Coupled Receptors
Paula Morales et al.
CANNABIS AND CANNABINOID RESEARCH (2017)
Apelin modulates pathological remodeling of lymphatic endothelium after myocardial infarction
Florence Tatin et al.
JCI INSIGHT (2017)
Prognostic value of plasma apelin concentrations at admission in patients with ST-segment elevation acute myocardial infarction
Jordi Sans-Rosello et al.
CLINICAL BIOCHEMISTRY (2017)
Canonical hedgehog signalling regulates hepatic stellate cell-mediated angiogenesis in liver fibrosis
Feng Zhang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Elabela/Toddler Is an Endogenous Agonist of the Apelin APJ Receptor in the Adult Cardiovascular System, and Exogenous Administration of the Peptide Compensates for the Downregulation of Its Expression in Pulmonary Arterial Hypertension
Peiran Yang et al.
CIRCULATION (2017)
Cannabinoid CB1 and CB2 Receptor Signaling and Bias
Mikkel Soes Ibsen et al.
CANNABIS AND CANNABINOID RESEARCH (2017)
Cyclooxygenase-2 contributes to the selective induction of cell death by the endocannabinoid 2-arachidonoyl glycerol in hepatic stellate cells
S. V. Siegmund et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
An Introduction to the Endogenous Cannabinoid System
Hui-Chen Lu et al.
BIOLOGICAL PSYCHIATRY (2016)
Cannabinoid receptor 2 (CB2) agonists and antagonists: a patent update
Paula Morales et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2016)
Utility of galectin-3 in predicting post-infarct remodeling after acute myocardial infarction based on extracellular volume fraction mapping
Rosario J. Perea et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
FAAH inhibitors in the limelight, but regrettably
Christophe Mallet et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2016)
Cerium oxide nanoparticles reduce steatosis, portal hypertension and display anti-inflammatory properties in rats with liver fibrosis
Denise Oro et al.
JOURNAL OF HEPATOLOGY (2016)
CB2 Cannabinoid Receptor Knockout in Mice Impairs Contextual Long-Term Memory and Enhances Spatial Working Memory
Yong Li et al.
NEURAL PLASTICITY (2016)
Endocannabinoid system and pregnancy
Fernando Correa et al.
REPRODUCTION (2016)
The effects of apelin treatment on a rat model of type 2 diabetes
Raziye Akcilar et al.
ADVANCES IN MEDICAL SCIENCES (2015)
Induction of chronic pancreatitis by pancreatic duct ligation activates BMP2, apelin, and PTHrP expression in mice
Cristiana Rastellini et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2015)
ELABELA Is an Endogenous Growth Factor that Sustains hESC Self-Renewal via the PI3K/AKT Pathway
Lena Ho et al.
CELL STEM CELL (2015)
Apelin receptors: From signaling to antidiabetic strategy
C. Chaves-Almagro et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Pathobiology of liver fibrosis: a translational success story
Youngmin A. Lee et al.
GUT (2015)
Elevated Levels of Endocannabinoids in Chronic Hepatitis C May Modulate Cellular Immune Response and Hepatic Stellate Cell Activation
Eleonora Patsenker et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Apela Regulates Fluid Homeostasis by Binding to the APJ Receptor to Activate Gi Signaling
Cheng Deng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Anandamide Drives Cell Cycle Progression Through CBI Receptors in a Rat Model of Synchronized Liver Regeneration
Simona Pisanti et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2015)
Role of Cannabinoid Receptor CB2 in HER2 Pro-oncogenic Signaling in Breast Cancer
Eduardo Perez-Gomez et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Proapoptotic effect of endocannabinoids in prostate cancer cells
O. Orellana-Serradell et al.
ONCOLOGY REPORTS (2015)
CB2 cannabinoid receptor agonist enantiomers HU-433 and HU-308: An inverse relationship between binding affinity and biological potency
Reem Smoum et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Oleoylethanolamide, an endogenous PPAR-α ligand, attenuates liver fibrosis targeting hepatic stellate cells
Ling Chen et al.
ONCOTARGET (2015)
Role of Cannabinoid Receptor CB2 in HER2 Pro-oncogenic Signaling in Breast Cancer
Eduardo Perez-Gomez et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Clinical Implications of the Serum Apelin Level on Portal Hypertension and Prognosis of Liver Cirrhosis
Yoo Li Lim et al.
Gut and Liver (2015)
Blockade of the apelin-APJ system promotes mouse liver regeneration by activating Kupffer cells after partial hepatectomy
Shohei Yoshiya et al.
JOURNAL OF GASTROENTEROLOGY (2015)
Overexpression of angiopoietin-2 in rats and patients with liver fibrosis. Therapeutic consequences of its inhibition
Montse Pauta et al.
LIVER INTERNATIONAL (2015)
Angiogenesis and Fibrogenesis in Chronic Liver Diseases
Claudia Bocca et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2015)
The regulatory peptide apelin: a novel inhibitor of renal interstitial fibrosis
Li-Yan Wang et al.
AMINO ACIDS (2014)
Essential Role of Apelin Signaling During Lymphatic Development in Zebrafish
Jun-Dae Kim et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
Cannabinoid Receptor 2 Counteracts Interleukin-17-Induced Immune and Fibrogenic Responses in Mouse Liver
Adrien Guillot et al.
HEPATOLOGY (2014)
Effect of apelin on the cardiac hemodynamics in hypertensive rats with heart failure
Hui Pang et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2014)
Early phytocannabinoid chemistry to endocannabinoids and beyond
Raphael Mechoulam et al.
NATURE REVIEWS NEUROSCIENCE (2014)
Effects of cannabinoid receptor type 2 on endogenous myocardial regeneration by activating cardiac progenitor cells in mouse infarcted heart
Wang YaBin et al.
SCIENCE CHINA-LIFE SCIENCES (2014)
Pancreatitis activates pancreatic apelin-APJ axis in mice
Song Han et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2013)
Cannabinoid Receptors Couple to NMDA Receptors to Reduce the Production of NO and the Mobilization of Zinc Induced by Glutamate
Pilar Sanchez-Blazquez et al.
ANTIOXIDANTS & REDOX SIGNALING (2013)
Fatty acid amide hydrolase but not monoacyl glycerol lipase controls cell death induced by the endocannabinoid 2-arachidonoyl glycerol in hepatic cell populations
Soeren V. Siegmund et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Structural features of the apelin receptor N-terminal tail and first transmembrane segment implicated in ligand binding and receptor trafficking
David N. Langelaan et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2013)
The apelin receptor inhibits the angiotensin II type 1 receptor via allosteric trans-inhibition
K. Siddiquee et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Factors Involved in Extracellular Matrix Turnover in Human Derived Cardiomyocytes
Gregori Casals et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2013)
Sustained Cardiovascular Actions of APJ Agonism During Renin-Angiotensin System Activation and in Patients With Heart Failure
Gareth D. Barnes et al.
CIRCULATION-HEART FAILURE (2013)
Modulating the endocannabinoid system in human health and disease successes and failures
Pal Pacher et al.
FEBS JOURNAL (2013)
The Intestinal Glucose-Apelin Cycle Controls Carbohydrate Absorption in Mice
Cedric Dray et al.
GASTROENTEROLOGY (2013)
Aldosterone directly affects apelin expression and secretion in adipocytes
He Jiang et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2013)
Involvement of the apelin receptor APJ in Fas-induced liver injury
Hiroaki Yasuzaki et al.
LIVER INTERNATIONAL (2013)
Apelin-APJ induces ICAM-1, VCAM-1 and MCP-1 expression via NF-κB/JNK signal pathway in human umbilical vein endothelial cells
Ying Lu et al.
AMINO ACIDS (2012)
A new cannabinoid CB2 receptor agonist HU-910 attenuates oxidative stress, inflammation and cell death associated with hepatic ischaemia/reperfusion injury
Bela Horvath et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Heterodimerization of human apelin and kappa opioid receptors: Roles in signal transduction
Yalin Li et al.
CELLULAR SIGNALLING (2012)
The epidemiology, pathogenesis and histopathology of fatty liver disease
Adam P. Levene et al.
HISTOPATHOLOGY (2012)
Adenoviral dominant-negative soluble PDGFRβ improves hepatic collagen, systemic hemodynamics, and portal pressure in fibrotic rats
V. Reichenbach et al.
JOURNAL OF HEPATOLOGY (2012)
Reversal of liver fibrosis by the antagonism of endocannabinoid CB1 receptor in a rat model of CCl4-induced advanced cirrhosis
Ferdinando A. Giannone et al.
LABORATORY INVESTIGATION (2012)
The Role of Apelin on the Alleviative Effect of Angiotensin Receptor Blocker in Unilateral Ureteral Obstruction-Induced Renal Fibrosis
Masashi Nishida et al.
NEPHRON EXTRA (2012)
Towards the use of cannabinoids as antitumour agents
Guillermo Velasco et al.
NATURE REVIEWS CANCER (2012)
Prevention of Fibrosis Progression in CCl4-Treated Rats: Role of the Hepatic Endocannabinoid and Apelin Systems
Vedrana Reichenbach et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
CB1 receptor antagonists: new discoveries leading to new perspectives
E. Kirilly et al.
Acta Physiologica (2011)
Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults
G. Vernon et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
The case for peripheral CB1 receptor blockade in the treatment of visceral obesity and its cardiometabolic complications
George Kunos et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes
Luciano De Petrocellis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Hypoxia and proinflammatory factors upregulate apelin receptor expression in human stellate cells and hepatocytes
Pedro Melgar-Lesmes et al.
GUT (2011)
Inhibition of Placental Growth Factor Activity Reduces the Severity of Fibrosis, Inflammation, and Portal Hypertension in Cirrhotic Mice
Christophe Van Steenkiste et al.
HEPATOLOGY (2011)
Overexpression of apelin receptor (APJ/AGTRL1) on hepatic stellate cells and sinusoidal angiogenesis in human cirrhotic liver
Hiroaki Yokomori et al.
JOURNAL OF GASTROENTEROLOGY (2011)
Apelin protects against angiotensin II-induced cardiovascular fibrosis and decreases plasminogen activator inhibitor type-1 production
Khandaker Siddiquee et al.
JOURNAL OF HYPERTENSION (2011)
Cannabinoid Receptor Type I Modulates Alcohol-Induced Liver Fibrosis
Eleonora Patsenker et al.
MOLECULAR MEDICINE (2011)
Unique pathway for anandamide synthesis and liver regeneration
Angelo A. Izzo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
PI3K/Akt signaling transduction pathway is involved in rat vascular smooth muscle cell proliferation induced by apelin-13
Changhui Liu et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2010)
Apelin and APJ regulation in adipose tissue and skeletal muscle of type 2 diabetic mice and humans
Cedric Dray et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2010)
The endocannabinoid system as a target for the treatment of neurodegenerative disease
Emma L. Scotter et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Acute Cardiovascular Effects of Apelin in Humans Potential Role in Patients With Chronic Heart Failure
A. G. Japp et al.
CIRCULATION (2010)
Apelin Mediates the Induction of Profibrogenic Genes in Human Hepatic Stellate Cells
Pedro Melgar-Lesmes et al.
ENDOCRINOLOGY (2010)
The endocannabinoid system and psychiatric disorders
Daniela Parolaro et al.
EXPERIMENTAL NEUROLOGY (2010)
Beneficial Paracrine Effects of Cannabinoid Receptor 2 on Liver Injury and Regeneration
Fatima Teixeira-Clerc et al.
HEPATOLOGY (2010)
Effects of Olmesartan on Apelin/APJ and Akt/Endothelial Nitric Oxide Synthase Pathway in Dahl Rats With End-stage Heart Failure
Hiromichi Fukushima et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2010)
Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis
Paolo Caraceni et al.
LIVER INTERNATIONAL (2010)
Plasma apelin levels in subjects with nonalcoholic fatty liver disease
Cemal Nuri Ercin et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2010)
Cannabinoids and the gut: New developments and emerging concepts
Angelo A. Izzo et al.
PHARMACOLOGY & THERAPEUTICS (2010)
Hypoxia: A Link between Fibrogenesis, Angiogenesis, and Carcinogenesis in Liver Disease
Olivier Rosmorduc et al.
SEMINARS IN LIVER DISEASE (2010)
Apelin decreases myocardial injury and improves right ventricular function in monocrotaline-induced pulmonary hypertension
Ines Falcao-Pires et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
Cannabinoid Type 1 Receptor Antagonism Delays Ascites Formation in Rats With Cirrhosis
Marco Domenicali et al.
GASTROENTEROLOGY (2009)
Vascular endothelial growth factor and angiopoietin-2 play a major role in the pathogenesis of vascular leakage in cirrhotic rats
P. Melgar-Lesmes et al.
GUT (2009)
Antagonism of the cannabinoid CB-1 receptor protects rat liver against ischaemia-reperfusion injury complicated by endotoxaemia
P. Caraceni et al.
GUT (2009)
The Insertion and Transport of Anandamide in Synthetic Lipid Membranes Are Both Cholesterol-Dependent
Eric Di Pasquale et al.
PLOS ONE (2009)
Endocannabinoids and Liver Disease. II. Endocannabinoids in the pathogenesis and treatment of liver fibrosis
Soeren V. Siegmund et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2008)
Endocannabinoids and liver disease. I. Endocannabinoids and their receptors in the liver
A. Mallat et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2008)
Retardation of retinal vascular development in apelin-deficient mice
Atsushi Kasai et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Loss of cannabinoid receptor 1 accelerates intestinal tumor growth
Dingzhi Wang et al.
CANCER RESEARCH (2008)
Hypoxia-induced apelin expression regulates endothelial cell proliferation and regenerative angiogenesis
Melanie Eyries et al.
CIRCULATION RESEARCH (2008)
Daily cannabis use: A novel risk factor of steatosis severity in patients with chronic hepatitis C
Christophe Hezode et al.
GASTROENTEROLOGY (2008)
Hepatic Stellate Cells Secrete Angiopoietin 1 That Induces Angiogenesis in Liver Fibrosis
Kojiro Taura et al.
GASTROENTEROLOGY (2008)
The hepatic apelin system:: A new therapeutic target for liver disease
Alessandro Principe et al.
HEPATOLOGY (2008)
Aspects of endocannabinoid signaling in periimplantation biology
Xiaofei Sun et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2008)
Multiple pathways involved in the biosynthesis of anandamide
Jie Liu et al.
NEUROPHARMACOLOGY (2008)
The transcriptional co-activator PGC-1α up regulates apelin in human and mouse adipocytes
Anne Mazzucotelli et al.
REGULATORY PEPTIDES (2008)
Regression of fibrosis after chronic stimulation of cannabinoid CB2 receptor in cirrhotic rats
Javier Munoz-Luque et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Antiangiogenic treatment with Sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats
Snia Tugues et al.
HEPATOLOGY (2007)
Bradykinin attenuates hepatocellular damage and fibrosis in rats with chronic liver injury
Pau Sancho-Bru et al.
GASTROENTEROLOGY (2007)
HIF-1 regulates hypoxia- and insulin-induced expression of apelin in adipocytes
Alexander J. Glassford et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
Endocannabinoids acting at CB1 receptors mediate the cardiac contractile dysfunction in vivo in cirrhotic rats
Sandor Batkai et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Regulation of PI3K/Akt/GSK-3 pathway by cannabinoids in the brain
Andres Ozaita et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Cannabinoid CB1 receptor inverse agonists and neutral antagonists:: Effects on food intake, food-reinforced behavior and food aversions
John D. Salamone et al.
PHYSIOLOGY & BEHAVIOR (2007)
Utility of plasma apelin and other indices of cardiac dysfunction in the clinical assessment of patients with dilated cardiomyopathy
Kati H. Miettinen et al.
REGULATORY PEPTIDES (2007)
Growth hormone induces apelin mRNA expression and secretion in mouse 3T3-L1 adipocytes
Susan Kralisch et al.
REGULATORY PEPTIDES (2007)
The G protein-coupled receptor Agtrl1b regulates early development of myocardial progenitors
Ian C. Scott et al.
DEVELOPMENTAL CELL (2007)
Apelin modulates aortic vascular tone via endothelial nitric oxide synthase phosphorylation pathway in diabetic mice
Jiu-Chang Zhong et al.
CARDIOVASCULAR RESEARCH (2007)
The acute effects of cannabinoids on memory in humans: a review
Mohini Ranganathan et al.
PSYCHOPHARMACOLOGY (2006)
Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo
Christopher M. Cox et al.
DEVELOPMENTAL BIOLOGY (2006)
TNFα up-regulates apelin expression in human and mouse adipose tissue
Daniele Daviaud et al.
FASEB JOURNAL (2006)
Plasma concentrations of the novel peptide apelin are decreased in patients with chronic heart failure
KS Chong et al.
EUROPEAN JOURNAL OF HEART FAILURE (2006)
Fatty acid amide hydrolase determines anandamide-induced cell death in the liver
SV Siegmund et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Cannabinoid signalling
DG Demuth et al.
LIFE SCIENCES (2006)
The endocannabinoid system as an emerging target of pharmacotherapy
Pal Pacher et al.
PHARMACOLOGICAL REVIEWS (2006)
Endocannabinoids affect neurological and cognitive function in thioacetamide-induced hepatic encephalopathy in mice
Y Avraham et al.
NEUROBIOLOGY OF DISEASE (2006)
Regulation of apelin mRNA expression by insulin and glucocorticoids in mouse 3T3-L1 adipocytes
L Wei et al.
REGULATORY PEPTIDES (2005)
Anandamide induces necrosis in primary hepatic stellate cells
SV Siegmund et al.
HEPATOLOGY (2005)
Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity
D Osei-Hyiaman et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Apelin signalling: a promising pathway from cloning to pharmacology
B Masri et al.
CELLULAR SIGNALLING (2005)
Increased anandamide induced relaxation in mesenteric arteries of cirrhotic rats:: role of cannabinoid and vanilloid receptors
M Domenicali et al.
GUT (2005)
Antifibrogenic role of the cannabinoid receptor CB2 in the liver
B Julien et al.
GASTROENTEROLOGY (2005)
Identification and characterisation of a novel splice variant of the human CB1 receptor
E Ryberg et al.
FEBS LETTERS (2005)
CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity
CR Trillou et al.
INTERNATIONAL JOURNAL OF OBESITY (2004)
Involvement of brain-derived neurotrophic factor in cannabinoid receptor-dependent protection against excitotoxicity
LG Khaspekov et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Circulating endogenous cannabinoid anandamide and portal, systemic and renal hemodynamics in cirrhosis
CM Fernández-Rodriguez et al.
LIVER INTERNATIONAL (2004)
Apelin has in vivo inotropic effects on normal and failing hearts
MF Berry et al.
CIRCULATION (2004)
Apelin (65-77) activates p70 S6 kinase and is mitogenic for umbilical endothelial cells
B Masri et al.
FASEB JOURNAL (2004)
Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release
N De Mota et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Regulatory roles for APJ, a seven-transmembrane receptor related to angiotensin-type 1 receptor in blood pressure in vivo
J Ishida et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain
T Bisogno et al.
JOURNAL OF CELL BIOLOGY (2003)
Lipopolysaccharide induces anandamide synthesis in macrophages via CD14/MAPK/phosphoinositide 3-kinase/NF-κB independently of platelet-activating factor
J Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Membrane cholesterol but not putative receptors mediates anandamide-induced hepatocyte apoptosis
KK Biswas et al.
HEPATOLOGY (2003)
Circulating and cardiac levels of apelin, the novel ligand of the orphan receptor APJ, in patients with heart failure
G Földes et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Inhibition of 5-lipoxygenase induces cell growth arrest and apoptosis in rat Kupffer cells:: implications for liver fibrosis
E Titos et al.
FASEB JOURNAL (2003)
The molecular logic of endocannabinoid signalling
D Piomelli
NATURE REVIEWS NEUROSCIENCE (2003)
The endogenous, immunologically active peptide apelin inhibits lymphocytic cholinergic activity during immunological responses
Y Horiuchi et al.
JOURNAL OF NEUROIMMUNOLOGY (2003)
APJ receptor mRNA expression in the rat hypothalamic paraventricular nucleus: Regulation by stress and glucocorticoids
AM O'Carroll et al.
JOURNAL OF NEUROENDOCRINOLOGY (2003)
Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility
I Szokodi et al.
CIRCULATION RESEARCH (2002)
2-arachidonoyl-sn-glycero-3-phosphate, an arachidonic acid-containing lysophosphatidic acid:: occurrence and rapid enzymatic conversion to 2-arachidonoyl-sn-glycerol, a cannabinoid receptor ligand, in rat brain
S Nakane et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2002)
International Union of Pharmacology. XXVII. Classification of cannabinoid receptors
AC Howlett et al.
PHARMACOLOGICAL REVIEWS (2002)
Endogenous cannabinoids: A new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat
J Ros et al.
GASTROENTEROLOGY (2002)
Endocannabinoids acting at vascular CB, receptors mediate the vasodilated state in advanced liver cirrhosis
S Bátkai et al.
NATURE MEDICINE (2001)
The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism
K Tatemoto et al.
REGULATORY PEPTIDES (2001)
Molecular properties of apelin: tissue distribution and receptor binding
Y Kawamata et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2001)
Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2
KR Kozak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Molecular and functional characteristics of APJ - Tissue distribution of mRNA and interaction with the endogenous ligand apelin
M Hosoya et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
The endocannabinoid system as a target for therapeutic drugs
D Piomelli et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2000)
分享论文
